Trials / Completed
CompletedNCT03209661
Vascular Effects of a Single Bout of Electronic Cigarette Use
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- University of Texas at Austin · Academic / Other
- Sex
- All
- Age
- 20 Years – 30 Years
- Healthy volunteers
- Accepted
Summary
Investigating the acute effects of a single use E-Cigarette upon vascular health.
Detailed description
Subjects will inhale e-cigarettes of 5.4%, 0%, and sham menthol inhaler to determine the effects upon to measures of vascular health. These measures will include Cardio-Ankle Vascular Index and Flow Mediated Dilation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | E-cigarette | E-Cigarette containing 5.4% nicotine will be administered to determine the effects on vascular function. |
| DRUG | Nicotine 0% | E-Cigarette containing 0% nicotine will be administered to determine the effects on vascular function. |
| DRUG | Menthol Inhalant Product | Menthol inhaler will be administered to determine the effects on vascular function. |
Timeline
- Start date
- 2017-04-28
- Primary completion
- 2018-08-01
- Completion
- 2018-08-31
- First posted
- 2017-07-06
- Last updated
- 2018-10-11
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03209661. Inclusion in this directory is not an endorsement.